NASDAQ
GenSight Biologics S.A. (GSGTF) has a free cash flow growth of 100.00% as of Friday, May 29, 2026. This represents a 209.27% increase compared to its 12-month average of 32.33%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.